Lars Wallentin - Concepedia

Author

Lars Wallentin

Also Known As

Jolien Roos-Hesselink, L WALLENTIN, L Wallentin, L. Wallentin, Lars Wallentin, S. Apostolakis, S. Yakubov, Wallentin, L.

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Uppsala University Hospital Uppsala University

About

Lars Wallentin is an author at Uppsala University Hospital specializing in cardiovascular disease, atherosclerosis, and heparins.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	356
2	Pathology	1	1	356
3	Pharmacology	1	1	356
4	Vascular Disease	1	1	356
5	Atherosclerosis	1	1	356

Lars Wallentin

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease Lars Wallentin, Christoph Varenhorst, Stefan James, European Heart Journal	2007	455
Low-Molecular-Weight Heparin (Fragmin) During Instability in Coronary Artery Disease (FRISC) Eva Swahn, Lars Wallentin The American Journal of Cardiology ThrombosisVascular DiseaseCardiovascular DiseaseAtherosclerosisPharmacology	1997	356
Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction Tibor Kempf, E. Bjorklund, S.‐O. Olofsson, European Heart Journal	2007	228
Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease Christoph arenhorst, Stefan James, John T. Brandt, Thrombosis and Haemostasis	2008	73
Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction—the ASSENT Plus study Lars Wallentin European Heart Journal	2003	55
Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA{middle dot}CER) trial Sergio Leonardi, Pierluigi Tricoci, HD White, European Heart Journal	2013	37
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS Jan Paul Ottervanger, Paul W. Armstrong, E.S. Barnathan, European Heart Journal	2004	36

Page 1